Universities Are Profiting From Blocking Drug-Price Reform

Jacobin

Far Left

High Factuality

Universities Are Profiting From Blocking Drug-Price Reform

Teaming up with Big Pharma and Wall Street, universities are profiting by fighting government efforts to curtail soaring drug prices. A case in point: UCLA has reaped more than a billion dollars from its development of Xtandi, a lifesaving cancer drug. A university building in Los Angeles, California. (Gary Coronado / Los Angeles Times via Getty Images) Research universities, many of them public, have joined forces with pharmaceutical companie…